Company / Operating Cash Flow per Share
Cytek Biosciences, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.04
FY2025
5-year range
-$0.09 / $0.49
FY2021-FY2025
Trend
-118.6%
vs FY2024
Sector context
#139 of 161
Health Care
What the data says
Cytek Biosciences, Inc.'s operating cash flow per share of $-0.04 is lower than 86% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-0.09 in FY2022 to $0.49 in FY2021.
Based on SEC 10-K filings.
-0.04 in FY2025.
Declined from $0.04 to $-0.04 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 161This company -$0.04 Sector average $6.67
▼
-100.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 118.6% year-over-year.
- Ranks #139 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.04 | -118.6% |
| FY2024 | $0.20 | +386.2% |
| FY2023 | $0.04 | +144.2% |
| FY2022 | -$0.09 | -118.9% |
| FY2021 | $0.49 | +4.3% |
| FY2020 | $0.46 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026